Ignite Creation Date:
2025-12-24 @ 4:12 PM
Ignite Modification Date:
2025-12-27 @ 10:47 AM
Study NCT ID:
NCT03533166
Status:
COMPLETED
Last Update Posted:
2018-05-23
First Post:
2018-04-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effects of a 0.03% CHX Mouth Rinse in Peri-implant Mucositis
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'interventionBrowseModule': {'meshes': [{'id': 'D002710', 'term': 'Chlorhexidine'}], 'ancestors': [{'id': 'D001645', 'term': 'Biguanides'}, {'id': 'D006146', 'term': 'Guanidines'}, {'id': 'D000578', 'term': 'Amidines'}, {'id': 'D009930', 'term': 'Organic Chemicals'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'TRIPLE', 'whoMasked': ['PARTICIPANT', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR']}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 54}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2015-11-04', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2018-04', 'completionDateStruct': {'date': '2017-04-07', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2018-05-22', 'studyFirstSubmitDate': '2018-04-18', 'studyFirstSubmitQcDate': '2018-05-22', 'lastUpdatePostDateStruct': {'date': '2018-05-23', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2018-05-23', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2017-03-25', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Change on bleeding on probing on implants', 'timeFrame': 'Change baseline-12 months', 'description': 'Bleeding on probing (BOP) on implants, evaluated dichotomously (presence/absence), considering a positive score when evident bleeding was observed within 15 s after gentle probing (Jepsen et al. 2015) at baseline, 3, 6, 9 and 12 months. Primary outcome would be considered for the change between baseline and 12 months\n\nOne blinded and calibrated investigator recorded BOP at 6 sites around implants, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA)\n\nCalibration was achieved in double measurement calibration sessions, with a gold standard, on six randomly selected patients within one week. The inter-examiner agreement resulting in kappa (k) values of 0.78 for BOP).'}], 'secondaryOutcomes': [{'measure': 'Bleeding on probing (BOP) on implants', 'timeFrame': 'Baseline', 'description': 'Bleeding on probing (BOP) on implants, evaluated dichotomously (presence/absence), considering a positive score when evident bleeding was observed within 15 s after gentle probing (Jepsen et al. 2015) at baseline, 3, 6, 9 and 12 months.\n\nOne blinded and calibrated investigator recorded BOP at 6 sites around implants, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA)\n\nCalibration was achieved in double measurement calibration sessions, with a gold standard, on six randomly selected patients within one week. The inter-examiner agreement resulting in kappa (k) values of 0.78 for BOP).'}, {'measure': 'Bleeding on probing (BOP) on implants', 'timeFrame': '3 months', 'description': 'Bleeding on probing (BOP) on implants, evaluated dichotomously (presence/absence), considering a positive score when evident bleeding was observed within 15 s after gentle probing (Jepsen et al. 2015) at baseline, 3, 6, 9 and 12 months.\n\nOne blinded and calibrated investigator recorded BOP at 6 sites around implants, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA)\n\nCalibration was achieved in double measurement calibration sessions, with a gold standard, on six randomly selected patients within one week. The inter-examiner agreement resulting in kappa (k) values of 0.78 for BOP).'}, {'measure': 'Bleeding on probing (BOP) on implants', 'timeFrame': '6 months', 'description': 'Bleeding on probing (BOP) on implants, evaluated dichotomously (presence/absence), considering a positive score when evident bleeding was observed within 15 s after gentle probing (Jepsen et al. 2015) at baseline, 3, 6, 9 and 12 months.\n\nOne blinded and calibrated investigator recorded BOP at 6 sites around implants, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA)\n\nCalibration was achieved in double measurement calibration sessions, with a gold standard, on six randomly selected patients within one week. The inter-examiner agreement resulting in kappa (k) values of 0.78 for BOP).'}, {'measure': 'Bleeding on probing (BOP) on implants', 'timeFrame': '9 months', 'description': 'Bleeding on probing (BOP) on implants, evaluated dichotomously (presence/absence), considering a positive score when evident bleeding was observed within 15 s after gentle probing (Jepsen et al. 2015) at baseline, 3, 6, 9 and 12 months.\n\nOne blinded and calibrated investigator recorded BOP at 6 sites around implants, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA)\n\nCalibration was achieved in double measurement calibration sessions, with a gold standard, on six randomly selected patients within one week. The inter-examiner agreement resulting in kappa (k) values of 0.78 for BOP).'}, {'measure': 'Bleeding on probing (BOP) on implants', 'timeFrame': '12 months', 'description': 'Bleeding on probing (BOP) on implants, evaluated dichotomously (presence/absence), considering a positive score when evident bleeding was observed within 15 s after gentle probing (Jepsen et al. 2015) at baseline, 3, 6, 9 and 12 months.\n\nOne blinded and calibrated investigator recorded BOP at 6 sites around implants, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA)\n\nCalibration was achieved in double measurement calibration sessions, with a gold standard, on six randomly selected patients within one week. The inter-examiner agreement resulting in kappa (k) values of 0.78 for BOP).'}, {'measure': 'Bleeding on probing (BOP) on teeth', 'timeFrame': 'Baseline', 'description': 'Bleeding on probing (BOP) on teeth, evaluated dichotomously (presence/absence), considering a positive score when evident bleeding was observed within 15 s after gentle probing\n\nOne blinded and calibrated investigator recorded BOP at 6 sites around all teeth, using aPCP15 periodontal probe (HuFriedy® , Chicago, IL, USA).'}, {'measure': 'Bleeding on probing (BOP) on teeth', 'timeFrame': '6 months', 'description': 'Bleeding on probing (BOP) on teeth, evaluated dichotomously (presence/absence), considering a positive score when evident bleeding was observed within 15 s after gentle probing\n\nOne blinded and calibrated investigator recorded BOP at 6 sites around all teeth, using aPCP15 periodontal probe (HuFriedy® , Chicago, IL, USA).'}, {'measure': 'Bleeding on probing (BOP) on teeth', 'timeFrame': '12 months', 'description': 'Bleeding on probing (BOP) on teeth, evaluated dichotomously (presence/absence), considering a positive score when evident bleeding was observed within 15 s after gentle probing\n\nOne blinded and calibrated investigator recorded BOP at 6 sites around all teeth, using aPCP15 periodontal probe (HuFriedy® , Chicago, IL, USA).'}, {'measure': 'Plaque on implants', 'timeFrame': 'Baseline', 'description': 'Modified plaque index (MPlI) measured at six sites per implant (Mombelli et al. 1987):\n\n* Score 0: no plaque detected;\n* Score 1: plaque only recognized by running the periodontal probe across the smooth marginal surface of the implant;\n* Score 2: plaque can be seen by the naked eye;\n* Score 3: abundance of soft matter.\n\nOne blinded and calibrated investigator recorded MPI at 6 sites around the selected implant, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA).\n\nCalibration was achieved in double measurement calibration sessions, with a gold standard , on six randomly selected patients within one week. The inter-examiner agreement resulting in kappa (k) values of 0.79 for MPlI.'}, {'measure': 'Plaque on implants', 'timeFrame': '6 months', 'description': 'Modified plaque index (MPlI) measured at six sites per implant (Mombelli et al. 1987):\n\n* Score 0: no plaque detected;\n* Score 1: plaque only recognized by running the periodontal probe across the smooth marginal surface of the implant;\n* Score 2: plaque can be seen by the naked eye;\n* Score 3: abundance of soft matter.\n\nOne blinded and calibrated investigator recorded MPI at 6 sites around the selected implant, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA).\n\nCalibration was achieved in double measurement calibration sessions, with a gold standard , on six randomly selected patients within one week. The inter-examiner agreement resulting in kappa (k) values of 0.79 for MPlI.'}, {'measure': 'Plaque on implants', 'timeFrame': '12 months', 'description': 'Modified plaque index (MPlI) measured at six sites per implant (Mombelli et al. 1987):\n\n* Score 0: no plaque detected;\n* Score 1: plaque only recognized by running the periodontal probe across the smooth marginal surface of the implant;\n* Score 2: plaque can be seen by the naked eye;\n* Score 3: abundance of soft matter.\n\nOne blinded and calibrated investigator recorded MPI at 6 sites around the selected implant, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA).\n\nCalibration was achieved in double measurement calibration sessions, with a gold standard , on six randomly selected patients within one week. The inter-examiner agreement resulting in kappa (k) values of 0.79 for MPlI.'}, {'measure': 'Plaque on teeth', 'timeFrame': 'Baseline', 'description': 'Modified plaque index (MPlI) measured at six sites per tooth\n\n* Score 0: no plaque detected;\n* Score 1: plaque only recognized by running the periodontal probe across the smooth marginal surface of the tooth\n* Score 2: plaque can be seen by the naked eye;\n* Score 3: abundance of soft matter.\n\nOne blinded and calibrated investigator recorded MPI at 6 sites around teeth using a PCP15 periodontal probe (HuFriedy® , Chicago, IL, USA).'}, {'measure': 'Plaque on teeth', 'timeFrame': '6 months', 'description': 'Modified plaque index (MPlI) measured at six sites per tooth\n\n* Score 0: no plaque detected;\n* Score 1: plaque only recognized by running the periodontal probe across the smooth marginal surface of the tooth\n* Score 2: plaque can be seen by the naked eye;\n* Score 3: abundance of soft matter.\n\nOne blinded and calibrated investigator recorded MPI at 6 sites around teeth using a PCP15 periodontal probe (HuFriedy® , Chicago, IL, USA).'}, {'measure': 'Plaque on teeth', 'timeFrame': '12 months', 'description': 'Modified plaque index (MPlI) measured at six sites per tooth\n\n* Score 0: no plaque detected;\n* Score 1: plaque only recognized by running the periodontal probe across the smooth marginal surface of the tooth\n* Score 2: plaque can be seen by the naked eye;\n* Score 3: abundance of soft matter.\n\nOne blinded and calibrated investigator recorded MPI at 6 sites around teeth using a PCP15 periodontal probe (HuFriedy® , Chicago, IL, USA).'}, {'measure': 'Probing depth on implants', 'timeFrame': 'Baseline', 'description': 'Probing depth (PD) defined as the distance in mm, between the bottom of the pocket and the peri-implant mucosal margin (six sites per implant).\n\nOne blinded and calibrated investigator recorded PD at 6 sites around implants, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA)\n\nCalibration was achieved in double measurement calibration sessions, with a gold standard, on six randomly selected patients within one week. The inter-examiner agreement resulted in a intraclass correlation coefficient (ICC)=0.93 for PD.'}, {'measure': 'Probing depth on implants', 'timeFrame': '6 months', 'description': 'Probing depth (PD) defined as the distance in mm, between the bottom of the pocket and the peri-implant mucosal margin (six sites per implant).\n\nOne blinded and calibrated investigator recorded PD at 6 sites around implants, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA)\n\nCalibration was achieved in double measurement calibration sessions, with a gold standard, on six randomly selected patients within one week. The inter-examiner agreement resulted in a intraclass correlation coefficient (ICC)=0.93 for PD.'}, {'measure': 'Probing depth on implants', 'timeFrame': '12 months', 'description': 'Probing depth (PD) defined as the distance in mm, between the bottom of the pocket and the peri-implant mucosal margin (six sites per implant).\n\nOne blinded and calibrated investigator recorded PD at 6 sites around implants, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA)\n\nCalibration was achieved in double measurement calibration sessions, with a gold standard, on six randomly selected patients within one week. The inter-examiner agreement resulted in a intraclass correlation coefficient (ICC)=0.93 for PD.'}, {'measure': 'Probing depth on teeth', 'timeFrame': 'Baseline', 'description': 'Probing depth (PD) defined as the distance in mm, between the bottom of the pocket and the gingival margin (six sites per tooth).\n\nOne blinded and calibrated investigator recorded PD at 6 sites around all teeth, using a PCP15 periodontal probe (HuFriedy® , Chicago, IL, USA).'}, {'measure': 'Probing depth on teeth', 'timeFrame': '6 months', 'description': 'Probing depth (PD) defined as the distance in mm, between the bottom of the pocket and the gingival margin (six sites per tooth).\n\nOne blinded and calibrated investigator recorded PD at 6 sites around all teeth, using a PCP15 periodontal probe (HuFriedy® , Chicago, IL, USA).'}, {'measure': 'Probing depth on teeth', 'timeFrame': '12 months', 'description': 'Probing depth (PD) defined as the distance in mm, between the bottom of the pocket and the gingival margin (six sites per tooth).\n\nOne blinded and calibrated investigator recorded PD at 6 sites around all teeth, using a PCP15 periodontal probe (HuFriedy® , Chicago, IL, USA).'}, {'measure': 'Crown-length implant', 'timeFrame': 'Baseline', 'description': 'Crown-length implant (CLI), defined as the distance in mm, between the incisal/occlusal portion of the crown and the peri-implant mucosal margin at the mid-buccal site.\n\nOne blinded and calibrated investigator recorded CLI around the selected implant, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA).\n\nCalibration was achieved in double measurement calibration sessions, with a gold standard , on six randomly selected patients within one week. The inter-examiner agreement resulted in a intraclass correlation coefficient of 0.96 for CLI.'}, {'measure': 'Crown-length implant', 'timeFrame': '6 months', 'description': 'Crown-length implant (CLI), defined as the distance in mm, between the incisal/occlusal portion of the crown and the peri-implant mucosal margin at the mid-buccal site.\n\nOne blinded and calibrated investigator recorded CLI around the selected implant, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA).\n\nCalibration was achieved in double measurement calibration sessions, with a gold standard , on six randomly selected patients within one week. The inter-examiner agreement resulted in a intraclass correlation coefficient of 0.96 for CLI.'}, {'measure': 'Crown-length implant', 'timeFrame': '12 months', 'description': 'Crown-length implant (CLI), defined as the distance in mm, between the incisal/occlusal portion of the crown and the peri-implant mucosal margin at the mid-buccal site.\n\nOne blinded and calibrated investigator recorded CLI around the selected implant, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA).\n\nCalibration was achieved in double measurement calibration sessions, with a gold standard , on six randomly selected patients within one week. The inter-examiner agreement resulted in a intraclass correlation coefficient of 0.96 for CLI.'}, {'measure': 'Recession on teeth', 'timeFrame': 'Baseline', 'description': 'Recession (REC), defined as the distance in mm, between the gingival margin and the cements-enamel junction.\n\nOne blinded and calibrated investigator recorded REC around all teeth using a PCP15 periodontal probe (HuFriedy® , Chicago, IL, USA).'}, {'measure': 'Recession on teeth', 'timeFrame': '6 months', 'description': 'Recession (REC), defined as the distance in mm, between the gingival margin and the cements-enamel junction.\n\nOne blinded and calibrated investigator recorded REC around all teeth using a PCP15 periodontal probe (HuFriedy® , Chicago, IL, USA).'}, {'measure': 'Recession on teeth', 'timeFrame': '12 months', 'description': 'Recession (REC), defined as the distance in mm, between the gingival margin and the cements-enamel junction.\n\nOne blinded and calibrated investigator recorded REC around all teeth using a PCP15 periodontal probe (HuFriedy® , Chicago, IL, USA).'}, {'measure': 'Microbiological outcomes_total counts', 'timeFrame': 'Baseline', 'description': 'Pooled subgingival samples were obtained from the two most inflamed accessible sites of the selected implant in each patient.\n\nSamples were taken with two consecutive sterile medium paper-points (#30, Maillefer, Ballaigues, Switzerland) that were kept in place for 10 s and then transferred into a screw-capped vial containing 1.5 ml of reduced transport fluid (RTF) (Syed \\& Loesche 1972). Samples were transported to the microbiology laboratory within 2 h, where aliquots of 0.1 mL were plated in different culture media.\n\nCounts were transformed in colony-forming units (CFU) per mL of the original sample. Total anaerobic counts and counts of selected periodontal pathogens (A. actinomycetemcomitans, Tannerella forsythia, Porphyromonas gingivalis, Prevotella intermedia/nigrescens, Parvimonas micra, Eikenella corrodens, Campylobacter rectus and Fusobacterium nucleatum) were calculated.'}, {'measure': 'Microbiological outcomes_total counts', 'timeFrame': '6 months', 'description': 'Pooled subgingival samples were obtained from the two most inflamed accessible sites of the selected implant in each patient.\n\nSamples were taken with two consecutive sterile medium paper-points (#30, Maillefer, Ballaigues, Switzerland) that were kept in place for 10 s and then transferred into a screw-capped vial containing 1.5 ml of reduced transport fluid (RTF) (Syed \\& Loesche 1972). Samples were transported to the microbiology laboratory within 2 h, where aliquots of 0.1 mL were plated in different culture media.\n\nCounts were transformed in colony-forming units (CFU) per mL of the original sample. Total anaerobic counts and counts of selected periodontal pathogens (A. actinomycetemcomitans, Tannerella forsythia, Porphyromonas gingivalis, Prevotella intermedia/nigrescens, Parvimonas micra, Eikenella corrodens, Campylobacter rectus and Fusobacterium nucleatum) were calculated.'}, {'measure': 'Microbiological outcomes_total counts', 'timeFrame': '12 months', 'description': 'Pooled subgingival samples were obtained from the two most inflamed accessible sites of the selected implant in each patient.\n\nSamples were taken with two consecutive sterile medium paper-points (#30, Maillefer, Ballaigues, Switzerland) that were kept in place for 10 s and then transferred into a screw-capped vial containing 1.5 ml of reduced transport fluid (RTF) (Syed \\& Loesche 1972). Samples were transported to the microbiology laboratory within 2 h, where aliquots of 0.1 mL were plated in different culture media.\n\nCounts were transformed in colony-forming units (CFU) per mL of the original sample. Total anaerobic counts and counts of selected periodontal pathogens (A. actinomycetemcomitans, Tannerella forsythia, Porphyromonas gingivalis, Prevotella intermedia/nigrescens, Parvimonas micra, Eikenella corrodens, Campylobacter rectus and Fusobacterium nucleatum) were calculated.'}, {'measure': 'Microbiological outcomes_frequency of detection', 'timeFrame': 'Baseline', 'description': 'The frequency of detection was calculated as presence/absence of each periodontal pathogen'}, {'measure': 'Microbiological outcomes_frequency of detection', 'timeFrame': '6 months', 'description': 'The frequency of detection was calculated as presence/absence of each periodontal pathogen'}, {'measure': 'Microbiological outcomes_frequency of detection', 'timeFrame': '12 months', 'description': 'The frequency of detection was calculated as presence/absence of each periodontal pathogen'}, {'measure': 'Microbiological outcomes_proportions', 'timeFrame': 'Baseline', 'description': 'The proportions for each bacterial species was calculated by dividing the counts of each pathogen by the total counts.'}, {'measure': 'Microbiological outcomes_proportions', 'timeFrame': '6 months', 'description': 'The proportions for each bacterial species was calculated by dividing the counts of each pathogen by the total counts.'}, {'measure': 'Microbiological outcomes_proportions', 'timeFrame': '12 months', 'description': 'The proportions for each bacterial species was calculated by dividing the counts of each pathogen by the total counts.'}, {'measure': 'Radiographic bone loss on implants', 'timeFrame': 'Baseline', 'description': 'Standardized periapical radiographs using the parallel technique (Rinn® system, Dentsply, Weybridge, United Kingdom) were used to evaluate changes in the radiographic marginal bone levels (MBL).\n\nScanned images were measured both at the mesial and distal sites using as landmarks the implant shoulder and the first bone implant contact (BIC) of the selected implant using an image analysis software (J-image).\n\nAfter a session of calibration (ICC=0.99), two investigators performed all the radiographic measurements.'}, {'measure': 'Radiographic bone loss on implants', 'timeFrame': '3 months', 'description': 'Standardized periapical radiographs using the parallel technique (Rinn® system, Dentsply, Weybridge, United Kingdom) were used to evaluate changes in the radiographic marginal bone levels (MBL).\n\nScanned images were measured both at the mesial and distal sites using as landmarks the implant shoulder and the first bone implant contact (BIC) of the selected implant using an image analysis software (J-image).\n\nAfter a session of calibration (ICC=0.99), two investigators performed all the radiographic measurements.'}, {'measure': 'Radiographic bone loss on implants', 'timeFrame': '12 months', 'description': 'Standardized periapical radiographs using the parallel technique (Rinn® system, Dentsply, Weybridge, United Kingdom) were used to evaluate changes in the radiographic marginal bone levels (MBL).\n\nScanned images were measured both at the mesial and distal sites using as landmarks the implant shoulder and the first bone implant contact (BIC) of the selected implant using an image analysis software (J-image).\n\nAfter a session of calibration (ICC=0.99), two investigators performed all the radiographic measurements.'}, {'measure': 'Staining', 'timeFrame': 'Baseline', 'description': 'Staining of teeth will be scored using the Gründemann modification of the stain index (GMSI) (Grundemann et al. 2000), recorded at nine areas per tooth (three mesial, three medial, three distal). Stain will be graded using the intensity stain index of Lobene (1968).'}, {'measure': 'Staining', 'timeFrame': '6 months', 'description': 'Staining of teeth will be scored using the Gründemann modification of the stain index (GMSI) (Grundemann et al. 2000), recorded at nine areas per tooth (three mesial, three medial, three distal). Stain will be graded using the intensity stain index of Lobene (1968).'}, {'measure': 'Staining', 'timeFrame': '12 months', 'description': 'Staining of teeth will be scored using the Gründemann modification of the stain index (GMSI) (Grundemann et al. 2000), recorded at nine areas per tooth (three mesial, three medial, three distal). Stain will be graded using the intensity stain index of Lobene (1968).'}, {'measure': 'Adverse effect', 'timeFrame': 'Baseline', 'description': 'A questionnaire will be filled to assess the patient-based variables and side effects, by the patients. They will be evaluated with a visual analogue scale (0-10)'}, {'measure': 'Adverse effect', 'timeFrame': '6 months', 'description': 'A questionnaire will be filled to assess the patient-based variables and side effects, by the patients. They will be evaluated with a visual analogue scale (0-10)'}, {'measure': 'Adverse effect', 'timeFrame': '12 months', 'description': 'A questionnaire will be filled to assess the patient-based variables and side effects, by the patients. They will be evaluated with a visual analogue scale (0-10)'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['Peri-implant mucositis', 'Chlorhexidine', 'CPC', 'Treatment'], 'conditions': ['Peri-implant Mucositis']}, 'referencesModule': {'references': [{'pmid': '32737664', 'type': 'DERIVED', 'citation': 'Bollain J, Pulcini A, Sanz-Sanchez I, Figuero E, Alonso B, Sanz M, Herrera D. Efficacy of a 0.03% chlorhexidine and 0.05% cetylpyridinium chloride mouth rinse in reducing inflammation around the teeth and implants: a randomized clinical trial. Clin Oral Investig. 2021 Apr;25(4):1729-1741. doi: 10.1007/s00784-020-03474-3. Epub 2020 Jul 31.'}, {'pmid': '30779246', 'type': 'DERIVED', 'citation': 'Pulcini A, Bollain J, Sanz-Sanchez I, Figuero E, Alonso B, Sanz M, Herrera D. Clinical effects of the adjunctive use of a 0.03% chlorhexidine and 0.05% cetylpyridinium chloride mouth rinse in the management of peri-implant diseases: A randomized clinical trial. J Clin Periodontol. 2019 Mar;46(3):342-353. doi: 10.1111/jcpe.13088.'}]}, 'descriptionModule': {'briefSummary': 'Aim: To evaluate the efficacy of a 0.03% chlorhexidine (CHX) and 0.05% cetyl pyridinium chloride (CPC) mouth rinse, as an adjunct to professionally and patient-administered mechanical plaque removal, in the treatment of peri-implant mucositis.\n\nMaterial and Methods: Patients displaying peri-implant mucositis in, at least, one implant were included in this randomized, double-blinded, clinical trial. Subjects received a conventional professional prophylaxis (at baseline and 6-month visits) and were instructed to regular oral hygiene practices and to rinse, twice daily, during one year, with a 0.03% CHX and 0.05% CPC mouth rinse, or a placebo. Clinical, radiographic and microbiological data were recorded at baseline, 6 and 12 months. Disease resolution was defined as the absence of bleeding on probing (BOP). Repeated measures ANOVA, Student-t and chi square tests were used.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD', 'ADULT', 'OLDER_ADULT'], 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* the presence of, at least, one dental implant with clinical signs of peri-implant mucositis, defined as gently bleeding on probing (BOP) and/or suppuration without progressive radiographic bone loss (after at least 1 year of functional loading)\n\nExclusion Criteria:\n\n* untreated or recurrent periodontitis \\[presence of nine or more sites with PD 5 mm and with full mouth bleeding score (FMBS) \\> 25%\\];\n* implants affected by peri-implantitis, (BOP and/or suppuration and progressive radiographic bone loss);\n* removable implant-retained prosthesis;\n* history of intake of systemic antibiotics within the previous month or other chronic systemic medications that could interfere with the study outcomes;\n* and women being pregnant or breast-feeding.'}, 'identificationModule': {'nctId': 'NCT03533166', 'briefTitle': 'Effects of a 0.03% CHX Mouth Rinse in Peri-implant Mucositis', 'organization': {'class': 'OTHER', 'fullName': 'Universidad Complutense de Madrid'}, 'officialTitle': 'Clinical and Microbiological Effects of a 0.03% Chlorhexidine Mouth Rinse in the Prevention of Peri-implant Diseases: a Randomized Clinical Trial', 'orgStudyIdInfo': {'id': '15/064'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Chlorhexidine', 'description': 'Mechanical treatment + 0.03% chlorhexidine + 0.05% CPC mouthrinse', 'interventionNames': ['Other: Chlorhexidine']}, {'type': 'PLACEBO_COMPARATOR', 'label': 'Placebo', 'description': 'Mechanical treatment + Placebo mouth rinse', 'interventionNames': ['Other: Placebo']}], 'interventions': [{'name': 'Chlorhexidine', 'type': 'OTHER', 'description': '0.03% Chlorhexidine + 0.05% CPC mouth rinse', 'armGroupLabels': ['Chlorhexidine']}, {'name': 'Placebo', 'type': 'OTHER', 'description': 'Placebo mouth rinse', 'armGroupLabels': ['Placebo']}]}, 'contactsLocationsModule': {'locations': [{'zip': '28040', 'city': 'Madrid', 'country': 'Spain', 'facility': 'Faculty of Dentistry, Univesity Complutense, Madrid', 'geoPoint': {'lat': 40.4165, 'lon': -3.70256}}], 'overallOfficials': [{'name': 'Mariano Sanz, Doctor', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'University Complutense Madrid (UCM)'}, {'name': 'David Herrera, Doctor', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'University Complutense Madrid'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Universidad Complutense de Madrid', 'class': 'OTHER'}, 'collaborators': [{'name': 'Dentaid SL', 'class': 'INDUSTRY'}], 'responsibleParty': {'type': 'SPONSOR'}}}}